FDA Inspection 786212 — Greater Baltimore Medical Center
The FDA completed an inspection of Greater Baltimore Medical Center on June 15, 2012 in Towson, MD. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 2 citations were issued during this inspection. Product area: Biologics.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- June 15, 2012
- Fiscal Year
- 2012
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Towson, MD (United States)
Citations
| ID | CFR | Description |
|---|---|---|
| 4378 | 21 CFR 211.188(b)(2) | Identity of major equipment and lines used |
| 76 | 21 CFR 606.100(b) | Establish, maintain and follow manufacturing SOPs |